UBS Lux Equity Fund Biotech USD vs Heimdal Utbytte

UBS Lux Equity Fund Biotech USD vs Heimdal Utbytte

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Heimdal Utbytte

  • Security

    Heimdal Utbytte N

  • Fee

    1.29%

  • ISIN

    NO0012948852

  • Holdings

    24

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Heimdal Utbytte, we have 28 holdings where SpareBank is the largest holding (5.1), followed by SpareBank 1 SMN (4.97) and DNB (4.9).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Heimdal Utbytte.

UBS Lux Equity Fund Biotech USD Heimdal Utbytte
1. Regeneron Pharmaceuticals Inc
10.04 %
1. SpareBank 1 Sør-Norge ASA
Norway
5.1 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. SpareBank 1 SMN
Norway
4.97 %
3. Moderna Inc
9.21 %
3. DNB Bank
Norway
4.9 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Storebrand
Norway
4.82 %
5. AbbVie Inc
USA
5.53 %
5. Gjensidige Forsikring
Norway
4.81 %
6. Gilead Sciences Inc
USA
4.66 %
6. Orkla Foods AS
Norway
4.46 %
7. Amgen Inc
4.3 %
7. Aker BP
Norway
4.43 %
8. BioNTech SE
4.13 %
8. Kongsberg Gruppen ASA
Norway
4.41 %
9. Karuna Therapeutics Inc
3.75 %
9. Protector Forsikring ASA
Norway
4.27 %
10. Royalty Pharma Plc
3.37 %
10. Equinor ASA
Norway
4.19 %
- 11. SpareBank 1 Nord-Norge
Norway
4.12 %
- 12. Sparebanken Vest
Norway
4 %
- 13. Mowi
Norway
3.6 %
- 14. Norconsult ASA
Norway
3.11 %
- 15. Telenor ASA
Norway
3.1 %
- 16. Schibsted A
Norway
2.64 %
- 17. SalMar ASA
Norway
2.03 %
- 18. Pareto Bank ASA
Norway
1.95 %
- 19. Subsea 7 SA
Norway
1.79 %
- 20. Essity B
Sweden
1.65 %
- 21. Atea
1.56 %
- 22. Securitas B
Sweden
1.46 %
- 23. Bouvet ASA
Norway
1.37 %
- 24. AstraZeneca
Sweden UK
1.33 %

The list of fund holdings was last updated on June 5, 2025.